Are you a medical doctor passionate about transforming the treatment landscape for obesity? Do you want a role where your clinical insight, strategic thinking, and communication skills will drive meaningful change for people living with obesity? If so, join our CagriSema Obesity Global Medical Affairs (GMA) team as Associate Global Medical Director— a role where science, medical leadership and patient impact come together.
The position
You will be part of a team of experienced medical doctors and scientists with clinical, academic and industry backgrounds who are motivated by drug development, medical education, evidence generation and high‑quality scientific communication. This role offers the opportunity to use your clinical experience, analytical skills and creativity to help develop and position therapies that will significantly improve outcomes for people living with obesity. You will provide timely, accurate and credible medical input in a mid-late state development project.
Key responsibilities
Collaborate closely with cross‑functional stakeholders (Clinical Development, Regulatory, Safety, Marketing, Market Access, and global affiliates) to shape medical strategy and ensure scientific consistency across activities. Engage with Key Opinion Leaders (KOLs), patient advocacy groups and healthcare professionals to drive scientific exchange and gather insights that optimize product development and patient care. Provide medical input to clinical trial design and protocol development, advise on investigator selection, and lead scientific dialogue at later stages based on trial results. Lead and contribute to publication plans and development of peer‑reviewed manuscripts, working with external authors, statisticians and medical writers. Develop internal and external medical guidance and educational materials to support clinical use, disease awareness and evidence‑based care. Support launch readiness by contributing medical perspectives to promotional, medical‑legal, and market access materials. Present data at internal meetings and international scientific conferences, representing the company in medical and scientific forums. Support the Global Medical Director with strategic and leadership activities, including cross‑functional project leadership.
Your profile
We are looking for candidates who bring both clinical credibility and strategic medical acumen:
Medical doctor degree with +5 years of experience in clinical medicine and/or research; PhD is an advantage but not mandatory. Experience in pharmaceutical industry and/or medical affairs, preferably with a focus on obesity, metabolic disease, or related comorbidities. Proven track record of leading cross‑functional projects in late‑stage clinical development or medical affairs, including involvement in global project teams or launch activities. Experience designing or interpreting real‑world evidence (RWE) studies, pragmatic trials, registries, observational research, or other non‑randomized evidence‑generation approaches is an advantage Strong stakeholder management skills, able to interact credibly with senior leaders, governance committees, academia and external experts. Excellent presentation and communication skills in professional English. Comfortable working in complex environments, with strong problem‑solving abilities, a results‑driven approach and a positive, collaborative mindset.
Why join us
At Novo Nordisk we don’t wait for change — we drive it. You will be part of a dynamic organization that encourages experimentation, values excellence, and supports career development across research, development, manufacturing and medical affairs. In this role you will make a tangible difference for people living with obesity by helping to shape how therapies are developed, communicated, and used globally.
About the department
The CagriSema team is part of the Obesity& area and is based in Søborg, Denmark — a multinational, high‑energy group that thrives on proactive collaboration and open communication, bringing an outgoing, can‑do attitude to both internal teamwork and external scientific engagement.
In GMA we build and deliver consistent, credible scientific communication across all stages of clinical development and commercialization. We value curiosity, inclusive collaboration, and an environment that encourages learning and professional growth. The team works closely with cross‑functional colleagues across Clinical Development, Regulatory, Safety, Marketing, Market Access and other HQ functions to develop and implement medical strategies that shape patient care.
The therapy area covers an exciting pipeline in obesity and related metabolic conditions, including late‑stage molecules aimed at weight management, comorbidity risk reduction and long‑term metabolic health. You will join a team that combines clinical excellence and innovative thinking to bring impactful therapies to patients worldwide.
Contact
For further information please contact Adriana Rendon, Director, Medical CagriSema Obesity or get to know us better by visiting www.novonordisk.com/careers.
Deadline
Please apply by 16th of February 2026.
Applications will be assessed on receipt and interviews may be scheduled before the deadline.
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
Please include a few sentences in your CV about why you are applying. A cover letter is optional.
We are committed to an inclusive recruitment process and equal opportunity for all candidates. We believe diverse perspectives and backgrounds make us better at improving patient care — and we aim to be the best company for the world.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.